Clinical data of patients with multiple sclerosis treated with glatiramer acetate
| Annual relapse rate at start | Annual relapse rate in study | EDSS at start of study | EDSS at end of study | |
| Lymph node swelling | 1.8 (1–3.5) | 0.33 (0–1) | 2.5 (0–3.5) | 2.5 (0–3.5) |
| No lymph node swelling | 1.5 (1–3.5) | 0.54 (0–1.8) | 2.5 (1–5) | 3 (0–6.5) |
Values are mean (relapse rate) or median (EDSS) (range).
CiteULike
Connotea
Delicious
Digg
Facebook
Google+
Mendeley
Reddit
Technorati
Twitter
Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of
JNNP.
View free sample issue >>
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
Online ISSN 1468-330X
Copyright © 2012 by the BMJ Publishing Group Ltd. All rights reserved.
